The Natural History of C. Trachomatis Urethral Infections in Men Who Have Sex with Women

SJ

Stephen Jordan

Principal Investigator

Status: Recruiting Ages: 18 Years - 100 Years Gender: Male Phase: N/A 1 Locations

Brief Description

What is the purpose of this study?

Chlamydia is the most common bacterial sexually transmitted infection (STI) in the United States and is caused by the bacteria Chlamydia trachomatis, or “CT” for short. CT infects both men and women. The purpose of this study is to understand what causes some men to resist CT infection, spontaneously clear CT, and some to resist antibiotic cure so we can design a vaccine and lower CT rates in both men and women. 

We will compare samples that we collect from men who are being treated for Chlamydia to healthy samples to further study sexually-transmitted co-infections and the immune system.

Who can take part?

We are recruiting healthy adult males (ages 18 and older) to participate as controls. To be eligible, you must not have had chlamydia before.

Detailed Description

What Happens During Study Participation

  • Study participation consists of one clinic visit that will last approximately 30 minutes.
  • The study visit will take place in the Bell Flower Clinic (BFC) in Indianapolis, IN or the IU Infectious Diseases Research area of the 5th 3rd Building, which is just down the hall from the BFC.
  • The study visit will involve questions about medical/health history, a physical examination and collection of blood, swabs, urine and saliva.

Incentive/Compensation

  • Participants will receive a gift card of up to $100 for completing the study visit.

Eligibility of study

Inclusion Criteria:

  • Cisgender men
  • Healthy
  • Self-identify as heterosexual

Exclusion Criteria:

  • Urogenital symptoms

  • History of an STI 

     

Interested in participating?

Enrollment in IU School of Medicine clinical trials is managed through our All IN for Health program. Many studies only accept people who are part of an invited group. Visit allinforhealth.info to connect with the study team, or contact your doctor to see if you are eligible.